FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 356:1990-1991 May 10, 2007 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Perspective by Charo, R. A. Perspective by Agosti, J. M. Editorial by Sawaya, G. F. Editorial by Syrjänen, S. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by The FUTURE II Study Group Related Article by Garland, S. M. Related Article by D'Souza, G. PubMed Citation

In this issue of the Journal, we publish three Original Articles,^1,2,3 two Perspective articles,^4,5 two editorials,^6,7 a letter to the editor,⁸ and an audio interview⁹ on the subject of human papillomavirus (HPV). We bring together this unique body of information in response to the enormity of the health problems that stem from HPV and the broad interest that has been kindled by the possibility of preventing HPV-related cervical cancer and other anogenital conditions through vaccination.

The HPV vaccine is the first vaccine explicitly designed to prevent cancer induced by a virus. (The hepatitis B vaccine was not primarily designed to . . . [Full Text of this Article]

Related Letters:

Mandating HPV Vaccination — Private Rights, Public Good
Stewart A. M.
Extract | Full Text | PDF  
N Engl J Med 2007; 356:1998-1999, May 10, 2007. Correspondence

This article has been cited by other articles:

• Raffle, A. E (2007). Challenges of implementing human papillomavirus (HPV) vaccination policy. BMJ 335: 375-377 [Full Text]